Market Overview:
The global glycomacropeptide (GMP) supplements market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing awareness about the benefits of GMP supplements among consumers and health professionals. Additionally, rising demand for GMP supplements from hypermarkets/supermarkets and online stores is also propelling the growth of this market. However, high cost associated with GMP supplements is restraining the growth of this market to some extent. Based on type, glycomacropeptide (GMP) supplements for adults segment accounted for majority share in 2017 and is projected to maintain its dominance throughout the forecast period. This can be attributed to increasing number of adult population who are becoming more health conscious and prefer consuming GMP supplements over other types available in the market.
 Supplements Industry Outlook.svg)
Product Definition:
GMP supplements are a source of glycomacropeptide (GMP), a peptide that is derived from whey protein. GMP has been shown to have anti-inflammatory and antioxidant properties, as well as appetite suppressant effects.
Glycomacropeptide Supplements For Adults:
GMP supplements are used to treat diarrhea, abdominal pain, and constipation. GMP is also used as a growth factor in various medical conditions such as cancer and arthritis. The main function of these products is to help repair damaged cells or tissues by stimulating the natural healing process.
Glycomacropeptide Supplements For Children:
GMP supplements are used to treat malnutrition, diarrhea, and abdominal pain in children. It is also used as a protein supplement for infants and young children. GMP is an amino acid that works as a building block for proteins. The body cannot produce this essential nutrient; therefore it must be consumed through food or supplements.
Application Insights:
The other application segment includes fitness centers, clinics and hospitals, and online retail. The demand for glycomacropeptide supplements in the hypermarket/supermarket is expected to be high as these stores have a wide range of products that cover various health concerns. Glycomacropeptide supplements are available in different forms such as tablets, capsules, liquid extract etc., which makes them more convenient for consumers to access compared to other healthcare solutions.
Medical stores are anticipated to account for the highest share owing to factors such as availability of healthcare professionals with advanced knowledge about nutrition-related issues coupled with increasing awareness among consumers regarding their health conditions and weight management goals.
Regional Analysis:
North America was the largest regional market in 2017 owing to high product demand from adults and children. The region is expected to maintain its dominance over the forecast period due to increasing cases of obesity, which can be treated by using glycomacropeptide supplements. In addition, rising awareness about health and fitness among people is driving the product demand in this region.
Asia Pacific is anticipated to witness significant growth during the forecast period owing to an increase in per capita income of consumers coupled with growing medical tourism industry. This will result into an increased adoption of GMP supplements for treatment of various diseases such as diabetes, obesity, cancer & tumor growth etc., thereby boosting market growth during the estimated time span.
Growth Factors:
- Increasing awareness about the benefits of GMP supplements among consumers.
- Rising demand for GMP supplements from athletes and bodybuilders.
- Growing popularity of GMP supplements as a weight loss aid.
- increasing research on the health benefits of GMP supplements .
Scope Of The Report
Report Attributes
Report Details
Report Title
Glycomacropeptide (GMP) Supplements Market Research Report
By Type
Glycomacropeptide Supplements For Adults, Glycomacropeptide Supplements For Children
By Application
Hypermarket/Supermarket, Medical Stores, Specialty Stores, Online Stores, Other
By Companies
Agropur Coopérative, MET-Rx Nutrition Inc, Benfatto Nutrition, Arla Foods, Nestlé Health Science, Right Food, Glanbia, Plc., AMCO Proteins
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Glycomacropeptide (GMP) Supplements Market Report Segments:
The global Glycomacropeptide (GMP) Supplements market is segmented on the basis of:
Types
Glycomacropeptide Supplements For Adults, Glycomacropeptide Supplements For Children
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hypermarket/Supermarket, Medical Stores, Specialty Stores, Online Stores, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agropur Coopérative
- MET-Rx Nutrition Inc
- Benfatto Nutrition
- Arla Foods
- Nestlé Health Science
- Right Food
- Glanbia, Plc.
- AMCO Proteins
 Supplements Market Overview.svg)
Highlights of The Glycomacropeptide (GMP) Supplements Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glycomacropeptide Supplements For Adults
- Glycomacropeptide Supplements For Children
- By Application:
- Hypermarket/Supermarket
- Medical Stores
- Specialty Stores
- Online Stores
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Glycomacropeptide (GMP) Supplements Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Supplements Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Glycomacropeptide (GMP) supplements are a type of dietary supplement that is derived from the amino acid glycine. Glycomacropeptide is claimed to help improve joint health, reduce inflammation, and support healthy skin.
Some of the major companies in the glycomacropeptide (gmp) supplements market are Agropur Coop©rative, MET-Rx Nutrition Inc, Benfatto Nutrition, Arla Foods, Nestl© Health Science, Right Food, Glanbia, Plc., AMCO Proteins.
The glycomacropeptide (gmp) supplements market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Glycomacropeptide (GMP) Supplements Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Glycomacropeptide (GMP) Supplements Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Glycomacropeptide (GMP) Supplements Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Glycomacropeptide (GMP) Supplements Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Glycomacropeptide (GMP) Supplements Market Size & Forecast, 2018-2028
4.5.1 Glycomacropeptide (GMP) Supplements Market Size and Y-o-Y Growth
4.5.2 Glycomacropeptide (GMP) Supplements Market Absolute $ Opportunity
Chapter 5 Global Glycomacropeptide (GMP) Supplements Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Glycomacropeptide (GMP) Supplements Market Size Forecast by Type
5.2.1 Glycomacropeptide Supplements For Adults
5.2.2 Glycomacropeptide Supplements For Children
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Glycomacropeptide (GMP) Supplements Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Glycomacropeptide (GMP) Supplements Market Size Forecast by Applications
6.2.1 Hypermarket/Supermarket
6.2.2 Medical Stores
6.2.3 Specialty Stores
6.2.4 Online Stores
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Glycomacropeptide (GMP) Supplements Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Glycomacropeptide (GMP) Supplements Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Glycomacropeptide (GMP) Supplements Analysis and Forecast
9.1 Introduction
9.2 North America Glycomacropeptide (GMP) Supplements Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Glycomacropeptide (GMP) Supplements Market Size Forecast by Type
9.6.1 Glycomacropeptide Supplements For Adults
9.6.2 Glycomacropeptide Supplements For Children
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Glycomacropeptide (GMP) Supplements Market Size Forecast by Applications
9.10.1 Hypermarket/Supermarket
9.10.2 Medical Stores
9.10.3 Specialty Stores
9.10.4 Online Stores
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Glycomacropeptide (GMP) Supplements Analysis and Forecast
10.1 Introduction
10.2 Europe Glycomacropeptide (GMP) Supplements Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Glycomacropeptide (GMP) Supplements Market Size Forecast by Type
10.6.1 Glycomacropeptide Supplements For Adults
10.6.2 Glycomacropeptide Supplements For Children
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Glycomacropeptide (GMP) Supplements Market Size Forecast by Applications
10.10.1 Hypermarket/Supermarket
10.10.2 Medical Stores
10.10.3 Specialty Stores
10.10.4 Online Stores
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Glycomacropeptide (GMP) Supplements Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Glycomacropeptide (GMP) Supplements Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Glycomacropeptide (GMP) Supplements Market Size Forecast by Type
11.6.1 Glycomacropeptide Supplements For Adults
11.6.2 Glycomacropeptide Supplements For Children
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Glycomacropeptide (GMP) Supplements Market Size Forecast by Applications
11.10.1 Hypermarket/Supermarket
11.10.2 Medical Stores
11.10.3 Specialty Stores
11.10.4 Online Stores
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Glycomacropeptide (GMP) Supplements Analysis and Forecast
12.1 Introduction
12.2 Latin America Glycomacropeptide (GMP) Supplements Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Glycomacropeptide (GMP) Supplements Market Size Forecast by Type
12.6.1 Glycomacropeptide Supplements For Adults
12.6.2 Glycomacropeptide Supplements For Children
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Glycomacropeptide (GMP) Supplements Market Size Forecast by Applications
12.10.1 Hypermarket/Supermarket
12.10.2 Medical Stores
12.10.3 Specialty Stores
12.10.4 Online Stores
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Glycomacropeptide (GMP) Supplements Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Glycomacropeptide (GMP) Supplements Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Glycomacropeptide (GMP) Supplements Market Size Forecast by Type
13.6.1 Glycomacropeptide Supplements For Adults
13.6.2 Glycomacropeptide Supplements For Children
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Glycomacropeptide (GMP) Supplements Market Size Forecast by Applications
13.10.1 Hypermarket/Supermarket
13.10.2 Medical Stores
13.10.3 Specialty Stores
13.10.4 Online Stores
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Glycomacropeptide (GMP) Supplements Market: Competitive Dashboard
14.2 Global Glycomacropeptide (GMP) Supplements Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Agropur Coopérative
14.3.2 MET-Rx Nutrition Inc
14.3.3 Benfatto Nutrition
14.3.4 Arla Foods
14.3.5 Nestlé Health Science
14.3.6 Right Food
14.3.7 Glanbia, Plc.
14.3.8 AMCO Proteins
